Micron Waste Technologies Inc. ('Micron' or the 'Company') (CSE: MWM, Frankfurt: 7FM2), is pleased to announce that its wholly-owned subsidiary, Micron Technologies Inc. ('Micron Technologies'), a manufacturer of personal protective equipment in Canada, registered with the United States Food and Drug Administration (the 'US FDA') on June 27, 2020.

Owners and operators of facilities that manufacture or distribute medical devices intended for use in the United States are required to be registered with the US FDA. Micron Technologies has registered as both a manufacturer and distributor of medical devices. The US FDA further requires the registration of each device that is manufactured and distributed by an owner or operator. Micron Technologies' Model F2100 3-ply Face Mask has been registered with the product classification 'Face Mask (Except N95 Respirator) For General Public/Healthcare Personnel Per lie Guidance' and its Model F2100-3 3-ply Surgical Face Mask has been registered with the product classification 'Mask, Surgical.'

About Micron Waste Technologies Inc.

Micron is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The Company, through its subsidiary Micron Technologies, is also manufacturing medical grade face masks compliant with ASTM F2100 Standards.

FORWARD LOOKING STATEMENTS

This news release includes certain statements that may be deemed 'forward-looking statements.' The use of any of the words 'anticipate', 'continue', 'estimate', 'expect', 'may', 'will', 'would', 'project', 'should', 'believe' and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. The forward-looking statements in this news release are made as of the date of this news release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements are subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such statements.

Contact:

Tel: 604-805-4602

Email: kal@bullruncapital.ca

(C) 2020 Electronic News Publishing, source ENP Newswire